Alcoa Corporation · AA · FY2025 Q3 · Calendar Q4 2025
Alcoa: Record Production Offsets Modest Revenue Decline
The latest analysis supports a more constructive operating picture: record production, higher margins and improved Midwest premium coverage strengthen the near-term case, while safety, tariff, project-execution and commodity-price risks limit confidence in sustained earnings growth.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about AA FY2025 Q3
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current analysis shifts from tariff-driven margin pressure to record production and full Midwest-premium coverage of Section 232 costs. It also adds the Wagerup gallium project, a long-term Massena power contract and anode-furnace investment, while highlighting a serious safety incident and the permanent Kwinana closure.
Guidance delta
Guidance sentiment was maintained; the outlook reflects lower capex and interest expense while tariff pressures remain.
Key takeaways
- Record aluminum production and higher margins offset a modest revenue decline.
- The Midwest premium now covers Section 232 tariff costs, improving U.S. profitability.
- Strategic initiatives include a Wagerup gallium plant, a Massena power contract and anode-furnace investment.
- A workplace fatality and ongoing project, tariff and commodity-price risks temper the improved operating picture.
Management priorities
- Maintain safety focus and operational stability.
- Advance the Wagerup gallium project and Western Australia mine approvals.
- Execute the Massena power contract and anode-bake-furnace investment.
- Bring the San Ciprian smelter to steady-state operation and manage the Kwinana closure.
Follow AA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Hold | Buy | Downgrade | Oct 22, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Oct 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 20, 2026 |
| B. Riley Securities | Buy | Buy | Maintain | Oct 20, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 7, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 7, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 18, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 17, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 9, 2026 |
| UBS | Buy | Buy | Maintain | Jun 30, 2026 |
| HSBC | Buy | Buy | Maintain | Oct 17, 2025 |
| Jefferies | Buy | Buy | Maintain | Jan 6, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Sep 4, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 20, 2023 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 10, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 10, 2022 |
| Bank of America | Buy | Neutral | Upgrade | Sep 8, 2020 |
| B. Riley FBR | Neutral | Neutral | Maintain | Apr 23, 2020 |
| Gabelli & Co. | Hold | Buy | Downgrade | Oct 21, 2019 |
| B. Riley | Buy | Buy | Maintain | Oct 17, 2019 |
| Macquarie | Neutral | Outperform | Downgrade | Jul 9, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Berenberg | Hold | Buy | Downgrade | Sep 22, 2017 |
| Clarksons Platou | Buy | Buy | Maintain | May 22, 2017 |
| Cowen & Co. | Outperform | Outperform | Maintain | Nov 7, 2016 |
| Seaport Global | Neutral | Neutral | Maintain | Sep 9, 2016 |
| Rosenblatt | Buy | Buy | Maintain | Apr 26, 2016 |
| Nomura | Neutral | Buy | Downgrade | Nov 9, 2015 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jun 29, 2015 |
| Stifel | Buy | Buy | Maintain | Jun 29, 2015 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Jun 22, 2015 |
| Sterne Agee | Neutral | Buy | Downgrade | Jun 22, 2015 |
| Standpoint Research | Buy | Hold | Upgrade | May 1, 2015 |
| Cleveland Research | Neutral | Neutral | Maintain | Apr 22, 2015 |
| Tigress Financial | Strong Buy | Buy | Upgrade | Oct 10, 2014 |
| Bernstein | Outperform | Outperform | Maintain | Sep 9, 2014 |
| Northcoast Research | Buy | Buy | Maintain | May 9, 2014 |
| DA Davidson | Neutral | Neutral | Maintain | Jan 31, 2014 |
| Wellington Shields | Hold | Buy | Downgrade | Nov 7, 2013 |
| Dahlman Rose | Hold | Buy | Downgrade | Sep 27, 2012 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 10, 2012 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $39.74. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Analyst unavailable | $62 | $41.12 | +56.0% | Oct 20, 2026 |
| Freedom Broker | Vitaly Kononov | $62 | $40.79 | +56.0% | Oct 20, 2026 |
| Citigroup | Analyst unavailable | $56 | $40.79 | +40.9% | Oct 20, 2026 |
| Barclays | Richard Garchitorena | $55 | $41.49 | +38.4% | Oct 14, 2026 |
| Wells Fargo | Analyst unavailable | $60 | $46.97 | +51.0% | Sep 18, 2026 |
| Argus Research | Analyst unavailable | $55 | $46.28 | +38.4% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $72 | $48.48 | +81.2% | Jul 9, 2026 |
| Morgan Stanley | Analyst unavailable | $53 | $49.01 | +33.4% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $70 | $52.14 | +76.1% | Jul 1, 2026 |
| UBS | Analyst unavailable | $68 | $54.17 | +71.1% | Jun 30, 2026 |
| Morgan Stanley | Analyst unavailable | $79 | $65.55 | +98.8% | Jun 11, 2026 |
| UBS | Daniel Major | $80 | $66.27 | +101.3% | May 22, 2026 |
| Wells Fargo | Analyst unavailable | $70 | $63.25 | +76.1% | May 7, 2026 |
| Argus Research | John Eade | $73 | $65.91 | +83.7% | Apr 27, 2026 |
| BMO Capital | Analyst unavailable | $75 | $73.27 | +88.7% | Apr 9, 2026 |
| Morgan Stanley | Carlos De Alba | $80 | $71.76 | +101.3% | Apr 8, 2026 |
| Wells Fargo | Timna Tanners | $68 | $66.36 | +71.1% | Mar 12, 2026 |
| Morgan Stanley | Analyst unavailable | $64 | $58.55 | +61.0% | Jan 26, 2026 |
| Wells Fargo | Analyst unavailable | $64 | $63.14 | +61.0% | Jan 23, 2026 |
| Wells Fargo | Analyst unavailable | $71 | $65.67 | +78.7% | Jan 13, 2026 |
| Wells Fargo | Analyst unavailable | $58 | $53.72 | +45.9% | Dec 23, 2025 |
| Morgan Stanley | Carlos De Alba | $52 | $45.55 | +30.9% | Dec 15, 2025 |
| UBS | Analyst unavailable | $48 | $47.67 | +20.8% | Dec 12, 2025 |
| Argus Research | Analyst unavailable | $45 | $37.74 | +13.2% | Oct 30, 2025 |
| Morgan Stanley | Analyst unavailable | $43.5 | $40.14 | +9.5% | Oct 24, 2025 |
| HSBC | Analyst unavailable | $41 | $37.13 | +3.2% | Oct 17, 2025 |
| Morgan Stanley | Analyst unavailable | $42.5 | $35.53 | +6.9% | Oct 8, 2025 |
| Wells Fargo | Analyst unavailable | $40 | $35.53 | +0.7% | Oct 7, 2025 |
| UBS | Daniel Major | $31 | $28.67 | -22.0% | May 15, 2025 |
| BMO Capital | Katja Jancic | $45 | $42.07 | +13.2% | Oct 17, 2024 |
| B.Riley Financial | Derek Hernandez | $50 | $42.07 | +25.8% | Oct 17, 2024 |
| Jefferies | Christopher LaFemina | $50 | $42.07 | +25.8% | Oct 17, 2024 |
| Wolfe Research | Timna Tanners | $41 | $37.73 | +3.2% | Oct 9, 2024 |
| Bank of America Securities | Lawson Winder | $52 | $39.44 | +30.9% | Oct 1, 2024 |
| UBS | Curt Woodworth | $38 | $31.19 | -4.4% | Aug 12, 2024 |
| B.Riley Financial | Derek Hernandez | $39 | $39.7 | -1.9% | Jul 2, 2024 |
| Morgan Stanley | Carlos De Alba | $50 | $39.64 | +25.8% | Jun 21, 2024 |
| Morgan Stanley | Carlos De Alba | $36.5 | $36.35 | -8.2% | Apr 22, 2024 |
| Loop Capital Markets | Katja Jancic | $37 | $35.47 | -6.9% | Apr 18, 2024 |
| Jefferies | Christopher LaFemina | $48 | $35.55 | +20.8% | Apr 18, 2024 |
| B.Riley Financial | Derek Hernandez | $31 | $35.55 | -22.0% | Apr 18, 2024 |
| BMO Capital | Katja Jancic | $37 | $35.55 | -6.9% | Apr 18, 2024 |
| Loop Capital Markets | Katja Jancic | $28 | $24.53 | -29.5% | Oct 19, 2023 |
| UBS | Analyst unavailable | $50 | $52.22 | +25.8% | Feb 1, 2023 |
| Morgan Stanley | Analyst unavailable | $56 | $47.28 | +40.9% | Dec 9, 2022 |
| Morgan Stanley | Carlos De Alba | $66 | $43.14 | +66.1% | Sep 16, 2022 |
| BMO Capital | David Gagliano | $55 | $48.05 | +38.4% | Aug 3, 2022 |
| Morgan Stanley | Carlos De Alba | $55 | $48.9 | +38.4% | Jun 22, 2022 |
| Morgan Stanley | Analyst unavailable | $96 | $65.19 | +141.6% | Apr 25, 2022 |
| Credit Suisse | Curt Woodworth | $82 | $82.53 | +106.3% | Apr 11, 2022 |
| Argus Research | David Coleman | $95 | $91.96 | +139.1% | Mar 26, 2022 |
| Deutsche Bank | Sathish Kasinathan | $90 | $73.71 | +126.5% | Mar 15, 2022 |
| Morgan Stanley | Carlos De Alba | $78 | $73.86 | +96.3% | Feb 14, 2022 |
| B.Riley Financial | Lucas Pipes | $55 | $61.18 | +38.4% | Jan 20, 2022 |
| BMO Capital | David Gagliano | $65 | $61.18 | +63.6% | Jan 20, 2022 |
| Jefferies | Christopher LaFemina | $75 | $61.39 | +88.7% | Jan 17, 2022 |
Track every rating change on AA the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAlcoa Corporation stands as a global industrial leader, primarily focused on the production and sale of bauxite, alumina, and aluminum products. Its extensive operations span multiple continents, including North America (United States, Canada), Europe (Spain, Iceland, Norway), South America (Brazil), and Australia, along with other international markets. The company's activities are strategically divided into three principal segments: Bauxite, Alumina, and Aluminum. Alcoa initiates its process with bauxite mining. This raw material is then refined into alumina, which is subsequently sold to customers for conversion into various industrial chemical products.…
Historical context
All AA earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTA-PA EIDP, Inc. | FY2026 Q3 · Calendar Q3 2026 | +232.7% | — | New-product growth cushions EIDP, but Brazil weakness drives a lower outlook |
| CTA-PB EIDP, Inc. USD 4.50 Cum Pfd Registered Shs | FY2026 Q3 · Calendar Q3 2026 | — | — | New-product growth held up, but Brazil weakness cut the EBITDA outlook |
| VYLR Vylor Inc. | FY2026 Q3 · Calendar Q4 2026 | +21.1% | -0.1% | Vylor reaffirms 2026 outlook as Brazil licensing model shifts |
| CTVA Corteva, Inc. | FY2026 Q3 · Calendar Q4 2026 | +231.9% | -19.6% | Corteva Q3: New Products Grow as Brazil Weakness Cuts Outlook |
| FNV Franco-Nevada Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.8% | -2.4% | Franco-Nevada Q3: stronger earnings, but revenue missed estimates |
| B Barrick Mining Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.8% | +4.2% | Barrick posts record Q3 earnings and free cash flow; guidance unchanged |
Latest beats and misses
Who reports nextBeat on EPS
- NBISFY2026 Q3 · November 12, 2026+141.5% EPS-16.8% move
- AMATFY2026 Q4 · November 12, 2026+2.5% EPS-3.6% move
- CSCOFY2027 Q1 · November 12, 2026+5.3% EPS+1.2% move
- ASNDFY2026 Q3 · November 12, 2026+38.7% EPS+3.0% move
- TTEKFY2026 Q4 · November 11, 2026+4.6% EPS+4.8% move
- CTA-PAFY2026 Q3 · July 31, 2026+232.7% EPS— move
Missed on EPS
- ECFY2026 Q3 · November 12, 2026-5.6% EPS+0.7% move
- CBRSFY2026 Q3 · November 12, 2026-333.5% EPS-3.3% move
- BNFY2026 Q3 · November 12, 2026-6.1% EPS-1.0% move
- NUFY2026 Q3 · November 12, 2026-2.8% EPS-4.0% move
- PBRFY2026 Q3 · November 10, 2026-13.0% EPS-2.5% move
- EMBJFY2026 Q3 · November 10, 2026-49.4% EPS+7.0% move
Get the AA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-17T00:40:40.232212+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T00:40:40.230469+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.